Powerful Medical

What is PMcardio?

PMcardio is a pocket-sized AI medical device for diagnosing and treating heart conditions. It is CE-marked as a Class IIb medical device for use in the European Union and the United Kingdom. The device uses AI to digitize and analyze ECGs, providing treatment guidance for heart problems. It can diagnose 38 cardiovascular diseases in under 5 seconds, and its portability makes it practical for doctors in a variety of clinical settings.

Who created PMcardio?

PMcardio was created by a team with complementary expertise:

• Martin Herman — Co-founder and CEO, recognized on the Forbes 30 Under 30 list.
• Viktor Jurasek — Co-founder and CPO, specializing in product and digital design.
• Dr. Robert Herman — Co-founder and CMO, combining medical knowledge with technology.
• Simon Rovder — CTO.
• Gabriela Rovder Sklencarova — Infrastructure expert.

The company’s mission is to use AI for accurate diagnoses and fast ECG analysis through a portable device.

What is PMcardio used for?

• Fast ECG analysis: Results in under 5 seconds.
• Broad disease coverage: Diagnoses 38 cardiovascular diseases.
• ECG digitization: AI-based digitizing, analysis, and treatment guidance.
• Portable diagnostics: Fits in a pocket for use anywhere.
• Improved care: Supports diagnosis in hospitals, emergency rooms, and primary care, enabling faster treatment decisions.

Who is PMcardio for?

PMcardio is intended for healthcare professionals, including doctors in hospitals, emergency care teams, and primary care providers.

Certification and availability

PMcardio is CE-marked for the EU and UK. It is not yet FDA-cleared for use in the USA. Healthcare professionals should consult the detailed Instructions for Use before starting, which covers indications, contraindications, and warnings.